Navigation Links
Research finds racial/ethnic disparities in health care among older male cancer survivors
Date:7/12/2013

ancer survivors did not receive the flu vaccination, compared with 22 percent of non-Hispanic white cancer survivors.

Similarly, 51 percent of African-Americans and 59 percent of Hispanic cancer survivors did not report receiving the pneumonia vaccine, compared with 29 percent of non-Hispanic whites.

"These findings are consistent with other reports of health care use among cancer survivors and suggest there may be differences in types of Medicare health plans, supplemental insurance and out-of-pocket costs among older survivors that could be contributing to this disparity," Palmer said.

Palmer said further study is needed to identify other factors that may influence racial/ethnic disparities among male survivors, such as patients' beliefs about care after cancer and patient-provider communication.


'/>"/>

Contact: Bonnie Davis
bdavis@wakehealth.edu
336-726-4977
Wake Forest Baptist Medical Center
Source:Eurekalert

Page: 1 2

Related medicine news :

1. UCLA Brain Injury Research Center gets NCAA funding for research on sports concussions
2. NIH awards $20 million over 5 years to train next generation of global health researchers
3. Researchers develop a new cell and animal model of inflammatory breast cancer
4. Researchers uncover a viable way for colorectal cancer patients to overcome drug resistance
5. Sexually abused boys at risk for more unsafe sex: UBC research
6. Researchers Find Gene Mutations That May Be a Key to Autism
7. LSUHSC research finds HPV-related head & neck cancers rising, highest in middle-aged white men
8. Researchers find evidence of banned antibiotics in poultry products
9. Presidential keynote address and new research highlights from the American Society of Pediatric Otolaryngology meeting
10. Scientific session and new research highlights
11. NJ stroke researchers report advances in spatial neglect research at AAN Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... Thompson HealthDay Reporter ... the womb to household chemicals known as phthalates might ... University researchers reported in a new study. Children ... asthma between age 5 and 11 if their mothers ... phthalates (pronounced thal-ates), the researchers found. The two phthalates ...
(Date:9/17/2014)... R.I. [Brown University] As Congress adjourns this month ... senators will step over on their way out the ... Repeal and Medicare Provider Payment Modernization Act of 2014. ... Surgery , Dr. Eli Adashi recounts what he and ... bipartisan bill. The perennial trouble with how Medicare pays ...
(Date:9/17/2014)... Boston Children’s Museum and From ... concert series, introducing young Museum visitors to musicians ... premier national platform celebrating the stories, talents, and ... young musicians featured will also be showcased on ... is fortunate to partner with the wonderful musicians ...
(Date:9/17/2014)... 2014 StartX , a nonprofit ... raising rounds of funding at its Summer Demo Day ... and media, was the first such gathering held at ... the university. The presentations were delivered on an expansive ... Labs, a 2,000 square foot life science facility that ...
(Date:9/17/2014)... 17, 2014 The in vitro diagnostics ... technology market, focusing on molecular diagnostics for conditions such ... genetic testing. The IVD market value is projected to ... of 2017. The major drivers of the market’s growth ... which is evidenced by the explosion for raid and ...
Breaking Medicine News(10 mins):Health News:Prenatal Exposure to Chemicals in Plastics Linked to Asthma Risk in Kids 2Health News:Prenatal Exposure to Chemicals in Plastics Linked to Asthma Risk in Kids 3Health News:Prenatal Exposure to Chemicals in Plastics Linked to Asthma Risk in Kids 4Health News:Failed Medicare payments law remains relevant 2Health News:Failed Medicare payments law remains relevant 3Health News:Boston Children's Museum Partners with From the Top to Offer Monthly Concert Series 2Health News:Boston Children's Museum Partners with From the Top to Offer Monthly Concert Series 3Health News:Stanford-affiliated StartX Showcases Startups, New HQ, and Growth of Stanford-StartX Fund 2Health News:Stanford-affiliated StartX Showcases Startups, New HQ, and Growth of Stanford-StartX Fund 3Health News:Stanford-affiliated StartX Showcases Startups, New HQ, and Growth of Stanford-StartX Fund 4Health News:Stanford-affiliated StartX Showcases Startups, New HQ, and Growth of Stanford-StartX Fund 5Health News:Stanford-affiliated StartX Showcases Startups, New HQ, and Growth of Stanford-StartX Fund 6Health News:World In Vitro Diagnostics Market Analysed by VPG in In-demand Research Report Available at MarketPublishers.com 2Health News:World In Vitro Diagnostics Market Analysed by VPG in In-demand Research Report Available at MarketPublishers.com 3
... Simon J. ... NJHCFFA. , ... --Simon J. Samaha, M.D., recently was confirmed by the New Jersey State Senate as one of ... (The Authority). , , , , ,Dr. Samaha is the President and Chief Executive Officer of ...
... Perkins Warns Houston "Abortion Super Center" Will Be Prototype ... Jan. 18 An estimated 10,000 people converged on ... across from the nation,s largest abortion facility.  Tony Perkins, president of ... Call to Conscience in Houston today to rally pro-life ...
... to ask simple question of male patients , MONDAY, ... strong warning sign that a man might be at ... problems, a long-running study indicates. , "We saw that ... men with erectile function still had a 40 percent ...
... experts stress that ,senior moments, don,t guarantee that dementia ... News) -- Mental lapses among older adults occur more ... new research finds. , Excessive daytime sleepiness, staring into ... fluctuations that often precede Alzheimer,s, say researchers from Washington ...
... 18 An urgent aid shipment containing 4,000 tents and ... Haitian coastal town of Jacmel. , Jacmel, 30 miles southwest of ... devastated by the recent earthquake with more than 350 people reported ... that 60 percent of buildings were damaged or destroyed. , An ...
... to Run in Honor of People With Cystic Fibrosis , ... Fibrosis Foundation,s most active volunteers will carry the Olympic Torch today in ... Opening Ceremony of the 2010 Olympic Winter Games. , Liz Burns ... than $600,000 for CF research, care and education programs. She is ...
Cached Medicine News:Health News:Simon J. Samaha, M.D., Appointed Public Member of New Jersey Health Care Facilities Financing Authority 2Health News:FRC's Tony Perkins Speaks to Rally of Ten Thousand Across from Nation's Largest Abortion Facility 2Health News:Erectile Dysfunction Predicts Heart Disease 2Health News:Frequent Mental Lapses May Precede Alzheimer's 2Health News:Frequent Mental Lapses May Precede Alzheimer's 3Health News:Haiti: Lifesaving Aid Makes Its Way Through to Quake-Hit Jacmel by Ship 2Health News:Cystic Fibrosis Foundation Volunteer to Carry Torch for Vancouver 2010 Olympic Winter Games 2
(Date:9/17/2014)... ROSEVILLE, Minn. , Sept. 17, 2014  Rebiotix Inc. ... of the company,s lead product candidate, RBX2660 (microbiota suspension) will ... the IDWeek 2014 conference in Philadelphia ... will be presented during the poster session on Thursday, October ... C. difficile Infection: 60-Day Interim Analysis of the ...
(Date:9/17/2014)... DALLAS , Sept. 17, 2014   OTEMR, ... 2014 Edition Complete EHR certification, which designates that the ... the Stage 1 and Stage 2 Meaningful Use measures ... and Reinvestment Act (ARRA).  ONETOUCH EMR 2.0 was certified ... an Office of the National Coordinator-Authorized Certification Body (ONC-ACB) ...
(Date:9/17/2014)... of people suffer from neck and arm pain as a ... FDA approved the launch of a clinical trial for the ... Spinal Kinetics, which may offer relief to people with cervical ... for Special Surgery (HSS), the number one orthopedic hospital in ... York City and in the Northeast participating in ...
Breaking Medicine Technology:PUNCH CD Study Drug Targeting Recurrent C. difficile Infection to be Presented at IDWeek 2014 2PUNCH CD Study Drug Targeting Recurrent C. difficile Infection to be Presented at IDWeek 2014 3PUNCH CD Study Drug Targeting Recurrent C. difficile Infection to be Presented at IDWeek 2014 4OTEMR, Inc.'s ONETOUCH EMR Achieves ONC HIT 2014 Edition COMPLETE EHR Certification from ICSA Labs 2OTEMR, Inc.'s ONETOUCH EMR Achieves ONC HIT 2014 Edition COMPLETE EHR Certification from ICSA Labs 3Cervical Disc Clinical Trial for People with Neck and Arm Pain Set to Begin at Hospital for Special Surgery 2
... 6 Reportlinker.com announces that a new ... catalogue. , Reportlinker Adds Gilead ... http://www.reportlinker.com/p0151769/Reportlinker-Adds-Gilead-Sciences-Inc-PharmaVitae-Profile.html , Introduction , This ... for Gilead in the prescription pharmaceutical sector. ...
... Oct. 6 Centocor Ortho Biotech Inc. and Schering-Plough ... European Commission has approved SIMPONI(TM) (golimumab) as a once-monthly, ... arthritis (RA), active and progressive psoriatic arthritis (PsA) and ... the European Union, SIMPONI is approved as a 50 ...
Cached Medicine Technology:Reportlinker Adds Gilead Sciences Inc.: PharmaVitae Profile 2Reportlinker Adds Gilead Sciences Inc.: PharmaVitae Profile 3Reportlinker Adds Gilead Sciences Inc.: PharmaVitae Profile 4SIMPONI(TM) (golimumab) Receives European Approval as Once-Monthly Subcutaneous Anti-TNF for Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis with Novel SmartJect(TM) Autoinjector 2SIMPONI(TM) (golimumab) Receives European Approval as Once-Monthly Subcutaneous Anti-TNF for Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis with Novel SmartJect(TM) Autoinjector 3SIMPONI(TM) (golimumab) Receives European Approval as Once-Monthly Subcutaneous Anti-TNF for Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis with Novel SmartJect(TM) Autoinjector 4SIMPONI(TM) (golimumab) Receives European Approval as Once-Monthly Subcutaneous Anti-TNF for Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis with Novel SmartJect(TM) Autoinjector 5SIMPONI(TM) (golimumab) Receives European Approval as Once-Monthly Subcutaneous Anti-TNF for Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis with Novel SmartJect(TM) Autoinjector 6SIMPONI(TM) (golimumab) Receives European Approval as Once-Monthly Subcutaneous Anti-TNF for Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis with Novel SmartJect(TM) Autoinjector 7SIMPONI(TM) (golimumab) Receives European Approval as Once-Monthly Subcutaneous Anti-TNF for Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis with Novel SmartJect(TM) Autoinjector 8SIMPONI(TM) (golimumab) Receives European Approval as Once-Monthly Subcutaneous Anti-TNF for Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis with Novel SmartJect(TM) Autoinjector 9SIMPONI(TM) (golimumab) Receives European Approval as Once-Monthly Subcutaneous Anti-TNF for Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis with Novel SmartJect(TM) Autoinjector 10
The Pan Retinal® 2.2 uniquely combines magnification nearly that of the 20D lens with a field of view approaching that of the 30D lens. Excellent for virtually every examination procedure, includ...
Provides exceptional resolution and fundus scanning capability. Excellent for small pupil diagnosis and treatment....
The Professional ophthalmoscope has been designed to ensure ultimate control. Lenses, graticules and filters can all be introduced at the touch of a fingertip without the need to pull away from the p...
... MK-2000 Keratome System provides ... wide range of applications. ... ultra-sharp stainless steel disposable ... sterile and ready to ...
Medicine Products: